Search hospitals > Washington > Seattle

Seattle Cancer Care Alliance

Claim this profile
Seattle, Washington 98109
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Prostate Cancer
Conducts research for Tumors
426 reported clinical trials
43 medical researchers
Photo of Seattle Cancer Care Alliance in SeattlePhoto of Seattle Cancer Care Alliance in SeattlePhoto of Seattle Cancer Care Alliance in Seattle

Summary

Seattle Cancer Care Alliance is a medical facility located in Seattle, Washington. This center is recognized for care of Cancer, Breast Cancer, Non-Small Cell Lung Cancer, Prostate Cancer, Tumors and other specialties. Seattle Cancer Care Alliance is involved with conducting 426 clinical trials across 456 conditions. There are 43 research doctors associated with this hospital, such as Michael Schweizer, Michael J Wagner, MD, Christina S. Baik, and Andrew L. Coveler.

Area of expertise

1Cancer
Global Leader
Seattle Cancer Care Alliance has run 124 trials for Cancer. Some of their research focus areas include:
Stage IV
Stage III
Stage II
2Breast Cancer
Global Leader
Seattle Cancer Care Alliance has run 58 trials for Breast Cancer. Some of their research focus areas include:
Stage IV
HER2 negative
Stage III

Top PIs

Clinical Trials running at Seattle Cancer Care Alliance

Non-Small Cell Lung Cancer
Cancer
Lung Cancer
Prostate Cancer
Lymphoma
Breast Cancer
Tumors
Myelodysplastic Syndrome
Follicular Lymphoma
Ovarian Cancer
Image of trial facility.

Crizotinib

for Non-Small Cell Lung Cancer

This study is evaluating whether a drug called crizotinib may help treat patients with non-small cell lung cancer.
Recruiting2 awards Phase 328 criteria
Image of trial facility.

Ramucirumab + Pembrolizumab vs Chemotherapy

for Non-Small Cell Lung Cancer

This phase III trial compares the effect of the combination of ramucirumab and pembrolizumab versus standard of care chemotherapy for the treatment of non-small cell lung cancer that is stage IV or that has come back after a period of improvement (recurrent). Ramucirumab is a monoclonal antibody that may prevent the growth of new blood vessels that tumors need to grow. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. This trial may help doctors find out if giving ramucirumab with pembrolizumab is more effective at treating patients with stage IV or recurrent non-small cell lung cancer than standard chemotherapy.
Recruiting2 awards Phase 310 criteria
Image of trial facility.

U3-1402

for Non-Small Cell Lung Cancer

This study is evaluating whether a drug called U3-1402 can help people with lung cancer.
Recruiting1 award Phase 118 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Seattle Cancer Care Alliance?
Seattle Cancer Care Alliance is a medical facility located in Seattle, Washington. This center is recognized for care of Cancer, Breast Cancer, Non-Small Cell Lung Cancer, Prostate Cancer, Tumors and other specialties. Seattle Cancer Care Alliance is involved with conducting 426 clinical trials across 456 conditions. There are 43 research doctors associated with this hospital, such as Michael Schweizer, Michael J Wagner, MD, Christina S. Baik, and Andrew L. Coveler.
Where is Seattle Cancer Care Alliance located?
**Seattle Cancer Care Alliance** - **Address:** 825 Eastlake Ave E, Seattle, WA.
Who should I call to ask about financial aid or insurance network?
Seattle Cancer Care Alliance (SCCA) provides financial assistance to eligible patients, including those with health insurance, based on income requirements. Patients interested in applying for financial assistance can contact the facility directly or submit an application. For assistance with insurance benefits and care options, SCCA's Patient Financial Services team is available at 800.304.1763.
What insurance does Seattle Cancer Care Alliance accept?
Seattle Cancer Care Alliance (SCCA) accepts a wide range of insurance plans, including but not limited to Premera Blue Cross, Regence BlueShield, Kaiser Permanente, and Medicare. It is important to verify coverage with your insurance provider as some plans, especially those from the Washington Healthplanfinder, may not cover cancer treatment at SCCA. SCCA is also in-network with numerous other insurance providers such as Boeing BCBS, Cigna PPO, Community Health Plan of Washington, and many more. Always confirm that your plan covers the necessary care at SCCA before scheduling an appointment.
What awards or recognition has Seattle Cancer Care Alliance received?
Seattle Cancer Care Alliance (SCCA) ranks among the top ten cancer hospitals in the nation, according to U.S. News & World Report, and is the leading cancer hospital in the Pacific Northwest. It has earned "High Performing" ratings for both colon cancer surgery and lung cancer surgery, showcasing care that surpasses the national average.